SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 450.00 |
| Enterprise Value ($M) | 464.87 |
| Book Value ($M) | 24.43 |
| Book Value / Share | 0.91 |
| Price / Book | 18.42 |
| NCAV ($M) | -10.67 |
| NCAV / Share | -0.40 |
| Price / NCAV | -42.16 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.07 |
| Return on Assets (ROA) | -0.12 |
| Return on Equity (ROE) | -0.25 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.29 |
| Current Ratio | 2.06 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 41.02 |
| Assets | 76.12 |
| Liabilities | 51.70 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 39.01 |
| Operating Income | -2.18 |
| Net Income | -3.82 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.97 |
| Cash from Investing | -40.01 |
| Cash from Financing | 32.59 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | EcoR1 Capital, LLC | 7.70 | 41.74 | |
| 13G/A | Opaleye Management Inc. | 10.34 | 5.85 | |
| 13D/A | Imprimis Pharmaceuticals, Inc. | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 30,996 | 158,931 | 19.50 | |
| 42,454 | 171,915 | 24.69 | |
| 34,587 | 150,330 | 23.01 | |
| 24,099 | 176,257 | 13.67 | |
| 41,285 | 245,419 | 16.82 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| EOLS – Evolus, Inc. | ESPR – Esperion Therapeutics, Inc. |
| ETNB – 89bio, Inc. | FATE – Fate Therapeutics, Inc. |
| FHTX – Foghorn Therapeutics Inc. |
Financial data and stock pages provided by
Fintel.io